Page 946 - Williams Hematology ( PDFDrive )

920 Part VI: The Erythrocyte Chapter 59: Polyclonal and Hereditary Sideroblastic Anemias 921

23. Bessis MC, Jensen WN: Sideroblastic anaemia, mitochondria and erythroblastic iron. 58. Jardine PE, Cotter PD, Johnson SA, et al: Pyridoxine-refractory congenital sideroblastic
Br J Haematol 11:49–51, 1965. anaemia with evidence for autosomal inheritance: Exclusion of linkage to ALAS2 at
24. Griggs RC: Lead poisoning: Hematologic aspects. Prog Hematol 4:117–137, 1964. Xp11.21 by polymorphism analysis. J Med Genet 31(3):213–218, 1994.
25. Jensen WN, Moreno G: [The ribosomes and basophilic granulations of erythrocytes in 59. Goodman JR, Hall SG: Accumulation of iron in mitochondria of erythroblasts. Br J
lead poisoning] [in French]. C R Hebd Seances Acad Sci 258:3596–3597, 1964. Haematol 13(3):335–340, 1967.
26. Jensen WN, Moreno GD, Bessis MC: An electron microscopic description of basophilic 60. Kushner JP, Barbuto AJ, Lee GR: An inherited enzymatic defect in porphyria cutanea
stippling in red cells. Blood 25:933–943, 1965. tarda: Decreased uroporphyrinogen decarboxylase activity. J Clin Invest 58(5):1089–1097,
27. Gehrmann G: Pyridoxine-responsive anaemias. Br J Haematol 11:86–91, 1965. 1976.
28. Harris JW, Whittington RM, Weisman R Jr, et al: Pyridoxine responsive anemia in the 61. Chauhan MS, Dakshinamurti K: Fluorometric assay of B6 vitamers in biological
human adult. Proc Soc Exp Biol Med 91(3):427–432, 1956. material. Clin Chim Acta 109(2):159–167, 1981.
29. Horrigan DL, Harris JW: Pyridoxine-responsive anemias in man. Vitam Horm 26:549– 62. Lee GR, Cartwright GE, Wintrobe MM: The response of free erythrocyte protoporphy-
571, 1968. rin to pyridoxine therapy in a patient with sideroachrestic (sideroblastic) anemia. Blood
30. Cartwright GE, Deiss A: Sideroblasts, siderocytes, and sideroblastic anemia. N Engl J 27(4):557–567, 1966.
Med 292(4):185–193, 1975. 63. Pasanen AV, Salmi M, Vuopio P, et al: Heme biosynthesis in sideroblastic anemia. Int J
31. Hammond E, Deiss A, Carnes WH, et al: Ultrastructural characteristics of siderocytes Biochem 12(5–6):969–974, 1980.
in swine. Lab Invest 21(4):292–297, 1969. 64. Pasanen AV, Eklof M, Tenhunen R: Coproporphyrinogen oxidase activity and porphy-
32. Koc S, Harris JW: Sideroblastic anemias: Variations on imprecision in diagnostic cri- rin concentrations in peripheral red blood cells in hereditary sideroblastic anaemia.
teria, proposal for an extended classification of sideroblastic anemias. Am J Hematol Scand J Haematol 34(3):235–237, 1985.
57(1):1–6, 1998. 65. Wiseman DH, May A, Jolles S, et al: A novel syndrome of congenital sideroblastic ane-
33. Fleming MD: The genetics of inherited sideroblastic anemias. Semin Hematol mia, B-cell immunodeficiency, periodic fevers, and developmental delay (SIFD). Blood
39(4):270–281, 2002. 122(1):112–123, 2013.
34. Furuyama K, Sassa S: Multiple mechanisms for hereditary sideroblastic anemia. Cell 66. Barton JR, Shaver DC, Sibai BM: Successive pregnancies complicated by idiopathic
Mol Biol (Noisy-le-grand) 48(1):5–10, 2002. sideroblastic anemia. Am J Obstet Gynecol 166(2):576–577, 1992.
35. Garby L, Sjolin S, Vahlquist B: Chronic refractory hypochromic anaemia with dis- 67. Pignon JM, Breton-Gorius J, Bachir D, Rochant H: Congenital sideroblastic anemia
turbed haem-metabolism. Br J Haematol 3(1):55–67, 1957. without clinical iron overload. A case report. Nouv Rev Fr Hematol 32(4):281–284, 1990.
36. Konopka L, Hoffbrand AV: Haem synthesis in sideroblastic anaemia. Br J Haematol 68. Murakami R, Takumi T, Gouji J, et al: Sideroblastic anemia showing unique response to
42(1):73–83, 1979. pyridoxine. Am J Pediatr Hematol Oncol 13(3):345–350, 1991.
37. Lee GR, MacDiarmid WD, Cartwright GE, et al: Hereditary, X-linked, sideroachrestic 69. Mason DY, Emerson PM: Primary acquired sideroblastic anaemia: Response to treat-
anemia. The isolation of two erythrocyte populations differing in Xga blood type and ment with pyridoxal-5-phosphate. Br Med J 1(5850):389–390, 1973.
porphyrin content. Blood 32(1):59–70, 1968. 70. Chillar RK, Johnson CS, Beutler E: Erythrocyte pyridoxine kinase levels in patients
38. McColl KE, Thompson GG, Moore MR, et al: Acute ethanol ingestion and haem bio- with sideroblastic anemia. N Engl J Med 295(16):881–883, 1976.
synthesis in healthy subjects. Eur J Clin Invest 10(2 Pt 1):107–112, 1980. 71. Nishibe H, Yamagata K, Goto H: A case of sideroblastic anaemia associated with
39. Pasanen AV, Vuopio P, Borgstrom GH, et al: Haem biosynthesis in refractory siderob- marked elevation of erythrocytic arginase activity. Scand J Haematol 15(1):17–21,
lastic anaemia associated with the preleukaemic syndrome. Scand J Haematol 27(1):35– 1975.
44, 1981. 72. Valentine WN, Konrad PN, Paglia DE: Dyserythropoiesis, refractory anemia, and
40. Tanaka M, Bottomley SS: Bone marrow delta-aminolevulinic acid synthetase activity in “preleukemia:” metabolic features of the erythrocytes. Blood 41(6):857–875, 1973.
experimental sideroblastic anemia. J Lab Clin Med 84(1):92–98, 1974. 73. Ritchey AK, Hoffman R, Dainiak N, et al: Antibody-mediated acquired sideroblastic
41. Vogler WR, Mingioli ES: Porphyrin synthesis and heme synthetase activity in pyridox- anemia: Response to cytotoxic therapy. Blood 54(3):734–741, 1979.
ine-responsive anemia. Blood 32(6):979–988, 1968. 74. Rochant H, Dreyfus B, Bouguerra M, Tont-Hat H: Hypothesis: Refractory anemias,
42. Heilmeyer L: Disturbances in Heme Synthesis. Charles C. Thomas, Springfield, IL, 1966. preleukemic conditions, and fetal erythropoiesis. Blood 39(5):721–726, 1972.
43. Kushner JP, Lee GR, Wintrobe MM, et al: Idiopathic refractory sideroblastic anemia: 75. Geschke W, Beutler E: Refractory sideroblastic and nonsideroblastic anemia: A review
Clinical and laboratory investigation of 17 patients and review of the literature. Medi- of 27 cases. West J Med 127(2):85–92, 1977.
cine (Baltimore) 50(3):139–159, 1971. 76. Napier I, Ponka P, Richardson DR: Iron trafficking in the mitochondrion: Novel path-
44. Cotter PD, Baumann M, Bishop DF: Enzymatic defect in “X-linked” sideroblastic ane- ways revealed by disease. Blood 105(5):1867–1874, 2005.
mia: Molecular evidence for erythroid delta-aminolevulinate synthase deficiency. Proc 77. Pandolfo M: Frataxin deficiency and mitochondrial dysfunction. Mitochondrion 2
Natl Acad Sci U S A 89(9):4028–4032, 1992. (1–2):87–93, 2002.
45. Bottomley SS: Congenital sideroblastic anemias. Curr Hematol Rep 5(1):41–49, 2006. 78. Ponka P: Tissue-specific regulation of iron metabolism and heme synthesis: Distinct
46. Fleming MD: Congenital sideroblastic anemias: Iron and heme lost in mitochondrial control mechanisms in erythroid cells. Blood 89(1):1–25, 1997.
translation. Hematology Am Soc Hematol Educ Program 2011:525–531, 2011. 79. Adams ML, Ostapiuk I, Grasso JA: The effects of inhibition of heme synthesis on the
47. Guernsey DL, Jiang H, Campagna DR, et al: Mutations in mitochondrial carrier fam- intracellular localization of iron in rat reticulocytes. Biochim Biophys Acta 1012(3):
ily gene SLC25A38 cause nonsyndromic autosomal recessive congenital sideroblastic 243–253, 1989.
anemia. Nat Genet 41(6):651–653, 2009. 80. Borova J, Ponka P, Neuwirt J: Study of intracellular iron distribution in rabbit reticulo-
48. Allikmets R, Raskind WH, Hutchinson A, et al: Mutation of a putative mitochondrial cytes with normal and inhibited heme synthesis. Biochim Biophys Acta 320(1):143–156,
iron transporter gene (ABC7) in X-linked sideroblastic anemia and ataxia (XLSA/A). 1973.
Hum Mol Genet 8(5):743–749, 1999. 81. Ponka P, Wilczynska A, Schulman HM: Iron utilization in rabbit reticulocytes. A
49. Hellier KD, Hatchwell E, Duncombe AS, et al: X-linked sideroblastic anaemia with study using succinylacetone as an inhibitor or heme synthesis. Biochim Biophys Acta
ataxia: Another mitochondrial disease? J Neurol Neurosurg Psychiatry 70(1):65–69, 720(1):96–105, 1982.
2001. 82. Richardson DR, Ponka P, Vyoral D: Distribution of iron in reticulocytes after inhibition
50. Pagon RA, Bird TD, Detter JC, et al: Hereditary sideroblastic anaemia and ataxia: An of heme synthesis with succinylacetone: Examination of the intermediates involved in
X-linked recessive disorder. J Med Genet 22(4):267–273, 1985. iron metabolism. Blood 87(8):3477–3488, 1996.
51. Raskind WH, Wijsman E, Pagon RA, et al: X-linked sideroblastic anemia and ataxia: 83. Harrison PM, Arosio P: The ferritins: Molecular properties, iron storage function and
Linkage to phosphoglycerate kinase at Xq13. Am J Hum Genet 48(2):335–341, cellular regulation. Biochim Biophys Acta 1275(3):161–203, 1996.
1991. 84. Shaw GC, Cope JJ, Li L, et al: Mitoferrin is essential for erythroid iron assimilation.
52. Maguire A, Hellier K, Hammans S, et al: X-linked cerebellar ataxia and sideroblastic Nature 440(7080):96–100, 2006.
anaemia associated with a missense mutation in the ABC7 gene predicting V411L. Br J 85. Ajioka RS, Phillips JD, Kushner JP: Biosynthesis of heme in mammals. Biochim Biophys
Haematol 115(4):910–917, 2001. Acta 1763(7):723–736, 2006.
53. Shimada Y, Okuno S, Kawai A, et al: Cloning and chromosomal mapping of a novel 86. Ponka P, Sheftel AD, Zhang AS: Iron targeting to mitochondria in erythroid cells.
ABC transporter gene (hABC7), a candidate for X-linked sideroblastic anemia with Biochem Soc Trans 30(4):735–738, 2002.
spinocerebellar ataxia. J Hum Genet 43(2):115–122, 1998. 87. Sheftel AD, Zhang AS, Brown C, et al: Direct interorganellar transfer of iron from endo-
54. Broker S, Meunier B, Rich P, et al: MtDNA mutations associated with sideroblas- some to mitochondrion. Blood 110(1):125–132, 2007.
tic anaemia cause a defect of mitochondrial cytochrome c oxidase. Eur J Biochem 88. Zhang AS, Sheftel AD, Ponka P: Intracellular kinetics of iron in reticulocytes: Evidence
258(1):132–138, 1998. for endosome involvement in iron targeting to mitochondria. Blood 105(1):368–375,
55. Gattermann N, Retzlaff S, Wang YL, et al: Heteroplasmic point mutations of mitochon- 2005.
drial DNA affecting subunit I of cytochrome c oxidase in two patients with acquired 89. Cox TM, O’Donnell MW, Aisen P, et al: Hemin inhibits internalization of transferrin
idiopathic sideroblastic anemia. Blood 90(12):4961–4972, 1997. by reticulocytes and promotes phosphorylation of the membrane transferrin receptor.
56. Seneca S, De Meirleir L, De Schepper J, et al: Pearson marrow pancreas syndrome: A Proc Natl Acad Sci U S A 82(15):5170–5174, 1985.
molecular study and clinical management. Clin Genet 51(5):338–342, 1997. 90. Iacopetta B, Morgan E: Heme inhibits transferrin endocytosis in immature erythroid
57. Casas K, Bykhovskaya Y, Mengesha E, et al: Gene responsible for mitochondrial myop- cells. Biochim Biophys Acta 805(2):211–216, 1984.
athy and sideroblastic anemia (MSA) maps to chromosome 12q24.33. Am J Med Genet 91. Ponka P, Neuwirt J: Regulation of iron entry into reticulocytes. I. Feedback inhibitory
A 127A(1):44–49, 2004. effect of heme on iron entry into reticulocytes and on heme synthesis. Blood 33(5):
690–707, 1969.

Kaushansky_chapter 59_p0915-0922.indd 921 9/17/15 3:18 PM